Chemfield Cellulose Divests Stake to Oji Holdings
Deal News | Mar 10, 2025 | BDA Partners
BDA Partners has successfully advised Chemfield Cellulose Pvt Ltd and its shareholders on the divestment of a strategic stake to Japan's Oji Holdings. Chemfield, a leader in developing microcrystalline cellulose (MCC) excipients and derivatives, has established a strong presence in the Indian market with its high-quality product line. This transaction will allow Oji Holdings to extend its value chain into high-value-added sectors by integrating MCC production into its existing pulp raw material business. BDA Partners played a critical role in facilitating this partnership by leveraging its sector expertise to position Chemfield for growth. Both companies anticipate leveraging Oji's resources and capabilities to enhance Chemfield's product offerings and market reach.
Sectors
- Pharmaceuticals
- Manufacturing
- Chemicals
Geography
- India – Chemfield Cellulose, the target company, is based in India.
- Japan – Oji Holdings, the acquiring company, is headquartered in Japan.
Industry
- Pharmaceuticals – Chemfield Cellulose operates in the pharmaceutical industry by manufacturing MCC excipients used in pharmaceutical formulations.
- Manufacturing – The article involves the manufacturing sector as Chemfield develops and manufactures MCC and its derivatives.
- Chemicals – Oji Holdings' expansion into MCC production places the deal within the chemicals sector, dealing with cellulose products.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Chemfield Cellulose Pvt Ltd | Target Company | Company | An Indian developer and manufacturer of microcrystalline cellulose (MCC) excipients. |
| Oji Holdings | Bidding Company | Company | A Japanese company expanding into high-value-added MCC production. |
| BDA Partners | Financial Advisor | Company | An advisory firm that facilitated the divestment of Chemfield's stake to Oji Holdings. |
| Aneesh Taneja | Director, Chemfield | Person | Involved in the strategic investment process at Chemfield. |
| Sanjay Singh | Head of India and Co-Head Healthcare, Asia, BDA Partners | Person | Played a key role in advising Chemfield on the deal. |